Max van Noesel

30PUBLICATIONS
117CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Peripheral nervous systemHaematological tumoursNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Mar 12, 2026
Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma.

Yvette A H Matser, André B P van Kuilenburg, Atia Samim

|Mar 04, 2026
Pituitary dysfunction in childhood after [177Lu]Lu-DOTATATE therapy.

Karen van Wessel, Bart de Keizer, Miranda P Dierselhuis

|Jan 28, 2026
Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk.

Rixt S Bruinsma, Wendy W J de Leng, Marta F Fiocco

|Dec 18, 2025
Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation Study.

Nina U Gelineau, Lieke M J van Zogchel, Boris De Carolis

|Sep 02, 2025
γδ T cells are the prime antitumoral T cells in pediatric neuroblastoma.

Suzanne M Castenmiller, Anne L Borst, Leyma Wardak

|Jun 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.

Steven G DuBois, Lucas Moreno, John Anderson

Pageof 5

Frequent Collaborators

9 joint publications

Daniel Orbach

9 joint publications

Andrea Ferrari

7 joint publications

Godelieve A M Tytgat

4 joint publications

Bernadette Brennan